Literature DB >> 19713005

[Renal function evaluation methods in the elderly: reliability and clinical implications].

Ana Gómez Carracedo1, Juan J Baztán Cortés.   

Abstract

Chronic renal disease (CRD) is found in a third of the Spanish population aged more than 65 years old. Detection and early treatment would increase survival and help to reduce associated cardiovascular morbidity and mortality as well as the risk of pharmacological iatrogeny. Determination of the glomerular filtration rate has traditionally been considered the best parameter for renal function evaluation, which should not be based exclusively on serum creatinine concentration or creatinine clearance. The application of predictive equations is useful in the diagnosis, classification and outpatient management of patients with CRD. Most studies performed in the elderly have found that the Modification of Diet in Renal Disease (MDRD-4) has greater precision and accuracy than the Cockcroft-Gault formula, and is considered the nomogram of choice in this age group. The Cockcroft-Gault formula can be used when rapid estimation of renal function or drug adjustments are required, so long as the limitations of this method are taken into account.

Entities:  

Mesh:

Year:  2009        PMID: 19713005     DOI: 10.1016/j.regg.2009.03.016

Source DB:  PubMed          Journal:  Rev Esp Geriatr Gerontol        ISSN: 0211-139X


  2 in total

Review 1.  Infective Endocarditis in the Elderly: Challenges and Strategies.

Authors:  Carlos Bea; Sara Vela; Sergio García-Blas; Jose-Angel Perez-Rivera; Pablo Díez-Villanueva; Ana Isabel de Gracia; Eladio Fuertes; Maria Rosa Oltra; Ana Ferrer; Andreu Belmonte; Enrique Santas; Mauricio Pellicer; Javier Colomina; Alberto Doménech; Vicente Bodi; Maria José Forner; Francisco Javier Chorro; Clara Bonanad
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-17

2.  Effectiveness of a drug dosing service provided by community pharmacists in polymedicated elderly patients with renal impairment--a comparative study.

Authors:  M Angeles Via-Sosa; Natali Lopes; Marian March
Journal:  BMC Fam Pract       Date:  2013-07-13       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.